On ECHEMI
Home > Drugs > Yichun Pharmaceutical Co., Ltd.

Yichun Pharmaceutical Co., Ltd.

  • Founded in:

    1996-05-14
  • Country:

    China China
  • Address:

    Cuidong High-tech Industrial Park, Wucui District, Yichun City, Heilongjiang Province
  • Tax NO.:

    91230700129583614Q
  • Registered Funds:

    35 million yuan
  • Website:

  • Email:

Related Drugs
Nifedipine Tablets
The main ingredient of this product is nifedipine.
Name Description Content CAS NO. Registered Holders
Nifedipine

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

More

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

21829-25-4 75
Pimidic acid tablets
The main component of this product is pipemidic acid; its chemical name is: 8-ethyl-5-oxo-5,8-dihydro-2-(1-piperazinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acid trihydrate. Molecular formula: C14H17N5O33H2O, molecular weight: 357.37.
Name Description Content CAS NO. Registered Holders
Pipemidic acid

Quinolone antibiotics interfere with bacterial DNA synthesis by acting on bacterial DNA gyrase, thus causing bacterial death. They have antibacterial effects on Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc.

More

Quinolone antibiotics interfere with bacterial DNA synthesis by acting on bacterial DNA gyrase, thus causing bacterial death. They have antibacterial effects on Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Serratia, Salmonella typhi, Shigella, Pseudomonas aeruginosa, etc.

51940-44-4 3
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.